Keynote Financial Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Keynote Financial Services's ABBV Position: Q2 2026 in Review
Keynote Financial Services reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $216K and leaving 38,262 shares worth $9.63M. The position accounts for 4.51% of the portfolio, ranked #2.
Keynote Financial Services first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Keynote Financial Services held 38,262 shares of AbbVie worth $9.63M as of Q2 2026.
- Keynote Financial Services sold 1,005 AbbVie shares in Q2 2026, an estimated $216K.
- AbbVie made up 4.51% of Keynote Financial Services's portfolio in Q2 2026, its #2 holding.
- Keynote Financial Services first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.